Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 29122-68-7
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15DAY
Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram
Supply Ability: G,KG,TON
CAS NO:: |
29122-68-7 |
Appearance:: |
White To Off-white Crystalline Solid |
Molecular Formula:: |
C14H22N2O3 |
Molecular Weight:: |
266.33600 |
EINECS NO:: |
249-451-7 |
MDL NO:: |
MFCD00057645 |
CAS NO:: |
29122-68-7 |
Appearance:: |
White To Off-white Crystalline Solid |
Molecular Formula:: |
C14H22N2O3 |
Molecular Weight:: |
266.33600 |
EINECS NO:: |
249-451-7 |
MDL NO:: |
MFCD00057645 |
Product Description:
Product Name: Atenolol CAS NO: 29122-68-7
Synonyms:
2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide;
4-(2-hydroxy-3-[(1-methylethyl)amino]propoxy)benzeneacetamide;
1-p-carbamoylmethylphenoxy-3-isopropylamino-2-propanol;
Chemical & Physical Properties:
Appearance: White to off-white crystalline solid
Assay :≥99.00%
Density: 1.125 g/cm3
Boiling Point: 508℃ at 760 mmHg
Melting Point: 154℃
Flash Point: 261.1℃
Storage Condition: Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
Vapor Pressure: 3.82E-11mmHg at 25℃
Safety Information:
RTECS: AC3600000
Safety Statements: S22; S24/25; S36; S26
HS Code: 2924299090
WGK Germany: 2
Risk Statements: R22; R36/37/38; R20/21/22
Hazard Code: Xn
Atenolol is a selective β1 receptor antagonist, a drug belonging to the group of beta blockers (sometimes written β-blockers), a class of drugs used primarily in cardiovascular diseases. Introduced in 1976, atenolol was developed as a replacement for propranolol in the treatment of hypertension. It works by slowing down the heart and reducing its workload. Unlike propranolol, atenolol does not readily pass through the blood–brain barrier, thus decreasing the incidence of central nervous system side effects.
Atenolol is one of the most widely used β-blockers in the United Kingdom and was once the first-line treatment for hypertension. However, recent studies indicate that atenolol may not reduce morbidity or mortality when used to treat hypertension, and may even increase mortality in some subgroups. In addition, the role for β-blockers in general in hypertension was downgraded in June 2006 in the United Kingdom, and later in the United States, as they are less appropriate than newer drugs, particularly in the elderly.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.